A new vaccine that targets inflamed brain cells linked with Alzheimer’s disease may hold the key to potentially preventing the neurological condition, scientists say.
The yet-to-be peer-reviewed research, presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2023 in Boston, tested the vaccine in mice to target cells producing proteins linked to aging in mice brains.
